Pfizer Inc.
- Price
- 24.54 USD
- Fair value
- 16.08 USD
- Discount to fair value
- −53%
- Mkt cap
- 139.86B
- P/E
- 18.0×
- P/B
- 1.62×
- EV
- 202.68B
- Div yield
- 6.99%
- ROE
- 9.0%
- Net margin
- 12.4%
Current price24.54USD
Fair value (est., median)16.08USD
UndervaluedFair valueOvervalued
+52.6% above fair valueWould need to fall ~34.5% to reach fair value.
Median ofDCF 16.08DDM 25.84Graham 23.68Residual Income 13.2Earnings Power 13.69
Health Check
34.5
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
—
Risks
- Trades 52.6% above estimated fair value.
- Low fair-value confidence — methods disagree or data is thin.
- Dividend payout looks stretched.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 19 years · FY2007–FY2025
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 73.64B | 96.48B | 55.23B | 63.63B | 62.58B |
| Net Income | 21.98B | 31.37B | 2.12B | 8.03B | 7.77B |
| Net Margin | 29.8% | 32.5% | 3.8% | 12.6% | 12.4% |
| Operating Cash Flow | 32.58B | 29.27B | 8.70B | 12.74B | 11.70B |
| OCF Margin | 44.2% | 30.3% | 15.8% | 20.0% | 18.7% |
| Capital Expenditure | 2.71B | 3.24B | 3.91B | 2.91B | 2.63B |
| Free Cash Flow | 29.87B | 26.03B | 4.79B | 9.84B | 9.07B |
| FCF Margin | 40.6% | 27.0% | 8.7% | 15.5% | 14.5% |
| FCF Conversion | 135.9% | 83.0% | 226.2% | 122.5% | 116.8% |
| EPS (Diluted) | 3.86/sh | 5.50/sh | 0.37/sh | 1.41/sh | 1.36/sh |
| Dividend / Share | — | 1.58/sh | 1.62/sh | 1.67/sh | 1.71/sh |
Dividend return (if you buy today)if you buy today
Dividend yield6.99%
Dividend / share1.71 USD
If you invest
USD
Shares (≈)407
Est. annual income697.76 USD
At this rate, dividends alone return your capital in ~14.3 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | 0.43 | 0.43 | — | 0.86 | 3.4% |
| 2025 | — | — | — | — | 1.71 | 6.7% |
| 2024 | — | — | — | — | 1.67 | 6.1% |
| 2023 | — | — | — | — | 1.62 | 5.0% |
| 2022 | — | — | — | — | 1.58 | 3.3% |
Corporate actions
DCash Dividend
0.43 USD /sh2026-07-24
DCash Dividend
0.43 USD /sh2026-05-08
SStock Split
1.054×2020-11-17
DCash Dividend
0.25 USD /sh2014-05-07
DCash Dividend
0.25 USD /sh2014-02-05
DCash Dividend
0.23 USD /sh2013-11-06
DCash Dividend
0.23 USD /sh2013-07-31
DCash Dividend
0.23 USD /sh2013-05-08
DCash Dividend
0.23 USD /sh2013-01-30
DCash Dividend
0.21 USD /sh2012-11-07
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
16.08 USD
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
25.84 USD
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
23.68 USD
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
13.20 USD
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
13.69 USD
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)16.08 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 9.84%
- CAPM cost of equity
- 12.00%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Pfizer Inc. regularly?
Starting year
- Invested
- 1K/yr · 43K total(1984 → today · 43 yrs)
- your value today is
- 196.4K USD
- Total return
- +356.8%(+134.7% Dividends · +222.1% Capital gain)
- Annualised (IRR)
- +8.6%
Invested43KUSD
Dividends57.9KUSD
Capital gain95.5KUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.